Shenyang Sunshine Pharmaceutical Co., Ltd.
UkraineAll drugs from this manufacturer
-
The drug is used to treat thrombocytopenia (low platelet count) caused by chemotherapy in patients with solid tumors, as well as to treat immune thrombocytopenia (ITP) if corticosteroids are ineffective. It is intended for patients at risk of bleeding.
Dosage form: solution for injection
Active substance Dosage recombinant human thrombopoietin 15000 IU/ml ATC: B02BX
-
The drug is used to treat anemia associated with chronic kidney disease (in children and adults), as well as anemia in patients receiving chemotherapy for tumors. It is also used for preoperative preparation to reduce the need for blood transfusions.
Dosage form: solution for injection
Active substance Dosage recombinant human erythropoietin 3000 IU/ml ATC: B03XA01
-
The drug is used to treat anemia associated with chronic kidney disease (in children and adults), as well as anemia in patients receiving chemotherapy for tumors or lymphomas. It is also used to prepare for surgical interventions to reduce the need for blood transfusions.
Dosage form: solution for injection
Active substance Dosage recombinant human erythropoietin 4000 IU/ml ATC: B03XA01
-
The drug is used to treat anemia associated with chronic kidney disease (in children and adults on dialysis or adults not on dialysis), as well as to treat anemia in patients receiving chemotherapy for tumors. It is also used for preoperative optimization to reduce the need for blood transfusions.
Dosage form: solution for injection
Active substance Dosage recombinant human erythropoietin 10000 IU/ml ATC: B03XA01
-
The drug is used to treat anemia associated with chronic renal failure (in children and adults), as well as to treat anemia in patients receiving chemotherapy for tumors or lymphomas. It is also used for preoperative preparation to reduce the need for blood transfusions.
Dosage form: solution for injection
Active substance Dosage recombinant human erythropoietin 2000 IU/ml ATC: B03XA01